Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill Executive, as Special Commercial and Technical Advisor
April 27 2022 - 9:15AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the
“Company”), an agricultural bioscience company, today named Willie
Loh, Ph.D., as a special advisor to the Board of Directors and
Management of the Company, effective immediately. Dr. Loh
previously served as Vice President, Market Development, Global
Edible Oils Division at Cargill Incorporated, the global food and
agriculture company.
“We are excited to have Willie join our team as
we progress towards commercialization of our Camelina platform for
oils. His extensive knowledge of the commercial landscape for
commodity and specialty oils, including omega-3 oils, making him
uniquely suited to an advisory role with us as we advance our
commercial plans for Camelina,” said Oliver Peoples, Ph.D., Chief
Executive Officer of Yield10 Bioscience. “His tenure and
significant experience in the oils market will enable him to
provide our team with important strategic market and technology
insights as we engage with market participants to commercialize
Camelina oil and meal.”
“An unprecedented global demand for vegetable
oil is currently being driven by oil requirements for biofuels,
human nutrition and animal feed as well as supply disruptions
anticipated by geopolitical circumstances,” said Dr. Loh. “Yield10
has made great strides developing Camelina as a new commercial crop
with the potential to address the growing gap between vegetable oil
supply and demand. Based on the positive characteristics of the
crop, I believe Camelina will be welcomed by the industry. I look
forward to working with the Yield10 team and contributing to the
Company's success.”
Willie retired in 2020 as Vice President for
Cargill’s Global Edible Oil Solutions group in North America, where
he had responsibilities for market development of novel oil
products and led its Project Management Office. Prior to this
assignment, Willie led marketing professionals responsible for
strategic planning, new business development, product management
and innovation in food ingredient oils, foodservice oils and
planting seed. Willie joined Cargill in 1995 and led the specialty
oils sales team for 10 years.
Willie received his Bachelor’s Degree in Biology
from Columbia. He has a Master’s Degree in Botany from Rutgers
University and a Ph.D. in Microbiology from the Ohio State
University. Willie also worked as a Post-Doctoral Research Fellow
in Cell and Molecular Biology at the University of Virginia. He has
published original research articles in Oil Chemistry, Oilseed
Biochemistry, Microbial Physiology and Plant Molecular Genetics and
has been granted more than a dozen patents in these areas.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural
bioscience company that is using its differentiated trait gene
discovery platform, the “Trait Factory”, to develop improved
Camelina varieties to produce proprietary seed products, and to
discover high value genetic traits for the agriculture and food
industries. Our goals are to efficiently establish a high value
seed products business based on developing superior varieties of
Camelina to produce biofuel feedstock oils, PHA bioplastics and
omega-3 (DHA+EPA) oils and to license our yield traits to major
seed companies for commercialization in major row crops, including
corn, soybean and canola. Yield10 is headquartered in Woburn, MA
and has an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please
visit www.yield10bio.com, or follow the Company on Twitter,
Facebook and LinkedIn.
(YTEN-G)
Safe Harbor for
Forward-Looking Statements
This press release contains forward-looking
statements which are made pursuant to the safe harbor provisions of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. The
forward-looking statements in this release do not constitute
guarantees of future performance. Investors are cautioned that
statements in this press release which are not strictly historical,
including, without limitation, the Company’s expectations regarding
Dr. Loh’s contributions and insights; Camelina’s potential to
address the gap between vegetable oil supply and demand; the belief
that Camelina will be welcomed by the vegetable oil industry; and
the Company’s goals and plans for commercialization, constitute
forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Yield10
Bioscience's filings with the Securities and Exchange Commission.
Yield10 assumes no obligation to update any forward-looking
information contained in this press release or with respect to the
matters described herein.
Contacts: Yield10
Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561)
479-8566, brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund,
eric@fischtankpr.com FischTank PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Sep 2023 to Sep 2024